Loading...
Omalizumab vs. placebo in the management of chronic idiopathic urticaria: a systematic review
OBJECTIVES: To examine the evidence derived from randomized controlled clinical trials on the efficacy and safety of omalizumab compared to placebo in controlling symptoms of chronic idiopathic urticaria/chronic spontaneous urticaria (CIU/CSU). DATA SOURCE: The electronic databases PubMed, Medline,...
Na minha lista:
| Udgivet i: | World Allergy Organ J |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4280746/ https://ncbi.nlm.nih.gov/pubmed/25566332 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40413-014-0050-z |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|